Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Its low valuation, with P/E ratio at 8.01 and 8.3 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● One of the major weak points of the company is its financial situation.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.